The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Determinants of VLDL-triglycerides production
Abstract
PURPOSE OF REVIEW: Plasma free fatty acids (FFA) are major substrates for hepatic VLDL-triglycerides (VLDL-TG) production. In addition, it is a common belief that VLDL-TG production is a substrate driven process primarily determined by systemic FFA delivery. This review summarizes recent research of our understanding of the regulation of VLDL-TG production. RECENT FINDINGS: Recent studies have shown that increasing FFA flux is not inevitably associated with increased VLDL-TG production. Exercise induced increase in FFA flux resulting in unchanged VLDL-TG production in lean patients as well as in obese patients with increased hepatic fat despite exercise reduced hepatic fat content. With respect to the other inseparable conditions of insulin resistance and hyperinsulinemia, recent studies demonstrate that increased hepatic VLDL-TG production precedes the insulin resistance-associated impairment of the regulation of hepatic glucose production, whereas isolated chronic hyperinsulinemia (insulinoma) was not associated with increased VLDL-TG production. Insulin has been shown to have acute potent temporary suppressing effect on VLDL-TG production and new data demonstrates that increased glucagon reduces VLDL-TG production. Finally, recent studies indicate that sex hormones, oestrogen and testosterone, have no or very modest impact on VLDL-TG production. SUMMARY: Regulation of hepatic VLDL-TG production involves interplay between systemic FFA delivery, hormonal, and nutritional factors that act in concert with hepatic fatty acid handling to regulate short-term and long-term VLDL-TG production. The results of recent studies underscore that our current understanding of these relationships is complex and needs further research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When measured using radiolabeled VLDL particles, the adipose storage rates of VLDL-TG fatty acids appear to similar in men (91) and women (100).”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [100]
Citations
Cites
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972 · cited 1×
“Firstly, the actual release rate of FFA from the visceral fat depots is only making a limited contribution to the totality of FFA uptake by the liver [3] and secondly, there appears to be a much stronger association between VLDL-TG production and liver fat content than with visceral fat volumes [4].”
BackgroundSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933 · cited 1×
“Firstly, the actual release rate of FFA from the visceral fat depots is only making a limited contribution to the totality of FFA uptake by the liver [3] and secondly, there appears to be a much stronger association between VLDL-TG production and liver fat content than with visceral fat volumes [4].”
BackgroundSelf-citationFatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · cited 1×
“However, the first part of this argument has recently been questioned [29] and it is important to consider the possibility that poorly”
BackgroundSelf-citationLewis, G. F., Uffelman, K. D., Szeto, L. W., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 502 · cited 2×
“Later, studies have shown that infusion of intralipid/heparin, in order to raise plasma FFA, increases VLDL-TG and VLDL-apoB100 secretion [13].”
BackgroundIncreased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418 · cited 1×
“The question whether the increased VLDL-TG production results from chronic hyperinsulinaemia or from other factors associated with insulin resistance is beyond the scope of the present review but was recently reviewed [28].”
BackgroundPhysical Activity and Exercise in the Regulation of Human Adipose Tissue Physiology
Thompson, D., Karpe, F., Lafontan, M., & Frayn, K. (2012) · Physiological Reviews · doi:10.1152/physrev.00012.2011 · Cited by 402 · cited 1×
“During physical exercise there is a massive increase in FFA flux from adipose tissue [23].”
BackgroundSelf-citationParks, E. J., Krauss, R. M., Christiansen, M. P., Neese, R. A., & Hellerstein, M. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6572 · Cited by 349 · cited 1×
“Moreover, during prolonged increase in carbohydrate ingestion newly synthesized VLDLTG contains a progressively greater fraction of glucose-derived fatty acids [1], whereas the overall VLDL-TG production is unaltered [17], unless a hypercaloric carbohydrate diet is ingested, in which case, production increases [18].”
BackgroundHavel, R. J., Kane, J. P., Balasse, E. O., Segel, N., & Basso, L. V. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106422 · Cited by 336 · cited 1×
“[12] who used a combination of FFA tracer and splanchnic arteriovenous balance techniques to demonstrate that the net amount of FFA taken up in the splanchnic bed correlates with the net splanchnic release of VLDL-TG into the hepatic vein in normolipidaemic and hyperlipidaemic patients.”
MethodFatty acid regulation of very low density lipoprotein production
Lewis, G. F. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00004 · Cited by 294 · cited 1×
“A common viewpoint, frequently stated in the literature, is that VLDL-TG production is a substratedriven process primarily determined by hepatic FFA delivery [11].”
Background
Research works printed but not linked: 2
- McQuaid, 2011, Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition D, iabetes, 60, 47
- Sondergaard, 2011, Impaired postprandial suppression of endogenous VLDL-TG secretion in type 2 diabetic men., Diabetes, 60, A190
Cited by
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440
Animal models of metabolic syndrome: a review
Wong, S. K., Chin, K.-Y., Suhaimi, F. H., Fairus, A., & Ima-Nirwana, S. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0123-9 · Cited by 371
“Plasma free fatty acids are major substrates for hepatic VLDLtriglycerides production [53].”
BackgroundMetabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315
Causes and consequences of hypertriglyceridemia
Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239
“Liver triglyceride is derived from a number of sources, uptake of fatty acids from the bloodstream (especially that released from visceral fat depots), release of fatty acids from stored triglyceride in cytoplasmic lipid droplets, uptake and hydrolysis of chylomicron remnants, and de novo lipogenesis (34, 35, 37, 78,…”
Background
Metadata
- Authors
- Nielsen, S., & Karpe, F.
- Affiliations
- Aarhus University Hospital (DK)
- Churchill Hospital (GB)
- Corresponding author
- Karpe, Fredrik
- Venue
- Current Opinion in Lipidology
- Published
- 2012-08
- Volume
- 23
- Issue
- 4
- Pages
- 321-326
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W1993594610
- Cited by
- 94
- References
- 41
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 9 · 2015: 10 · 2014: 9 · 2013: 6 · 2012: 1
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sundhed og Sygdom, Det Frie Forskningsråd
- British Heart Foundation
- Novo Nordisk Fonden
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- VLDL triglycerides, free fatty acids, physical activity, liver fat, insulin resistance, hyperinsulinemia, insulin, glucagon, sex hormones, estrogen, testosterone, hepatic glucose production
- MeSH terms
- Animals, Fatty Acids, Nonesterified, Glucagon, Hormones, Humans, Insulin, Lipoproteins, VLDL, Triglycerides, Exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determinants of VLDL-triglycerides production. https://app.cochat.ai/papers/10.1097/mol.0b013e3283544956
- The paper
- Nielsen, S., & Karpe, F. (2012). Determinants of VLDL-triglycerides production. Current Opinion in Lipidology. https://doi.org/10.1097/mol.0b013e3283544956
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.